◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Hemostemix Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 1.3M 447,847 1.0M 969,345 261,985
General And Administrative Expense 1.2M 425,797 954,603 958,016 258,554
Research And Development 401,551 2,747 0.00 0.00 0.00
Depreciation And Amortization In Income Statement 11.00 12.00 12.00 25.00 25.00
Other Operating Expenses 66,482 31,256 31,870 45,825 11,659
Operating Expense 1.8M 481,862 1.0M 1.0M 273,669
Operating Income -1.8M -481,862 -1.0M -1.0M -273,669
EBIT -305,193 -134,800 -1.1M -1.1M -157,458
Interest Expense 192,562 172,852 166,177 162,711 157,101
Interest Expense Non Operating 192,562 172,852 166,177 162,711 157,101
Net Interest Income -193,394 -173,124 -166,177 -171,687 -157,387
Other Income Expense 1.5M 347,334 -82,997 -120,083 116,497
Other Non Operating Income Expenses 315,781 306,837 -- -- --
Special Income Charges 985,067 -- -- 0.00 0.00
Gain On Sale Of Security 153,082 40,497 -82,997 -120,083 116,497
Pretax Income -497,755 -307,652 -1.3M -1.3M -314,559
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00
Net Income From Continuing And Discontinued Operation -497,755 -307,652 -1.3M -1.3M -314,559
Net Income From Continuing Operation Net Minority Interest -497,755 -307,652 -1.3M -1.3M -314,559
Net Income Including Noncontrolling Interests -497,755 -307,652 -1.3M -1.3M -314,559
Net Income Common Stockholders -497,755 -307,652 -1.3M -1.3M -314,559
Net Income -497,755 -307,652 -1.3M -1.3M -314,559
EBITDA -305,182 -134,788 -1.1M -1.1M -157,433
Normalized EBITDA -1.4M -175,285 -1.0M -1.0M -273,930
Reconciled Depreciation 11.00 11.00 12.00 25.00 25.00
Basic EPS -0.00 -0.00 -0.01 -- -0.00
Diluted EPS -0.00 -0.00 -0.01 -- -0.00
Basic Average Shares 146.5M 146.5M 95.1M -- 87.1M
Diluted Average Shares 146.5M 146.5M 95.1M -- 87.1M
Total Unusual Items 1.1M 40,497 -82,997 -120,083 116,497
Total Unusual Items Excluding Goodwill 1.1M 40,497 -82,997 -120,083 116,497
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00
Normalized Income -1.6M -348,149 -1.2M -1.2M -431,056
Depreciation Amortization Depletion Income Statement 11.00 12.00 12.00 25.00 25.00
Depreciation Income Statement 11.00 12.00 12.00 25.00 25.00
Diluted NI Availto Com Stockholders -497,755 -307,652 -1.3M -1.3M -314,559
Net Income Continuous Operations -497,755 -307,652 -1.3M -1.3M -314,559
Net Non Operating Interest Income Expense -193,394 -173,124 -166,177 -171,687 -157,387
Other Gand A 709,227 410,939 407,053 639,462 254,411
Other Special Charges -985,067 -- -- -- --
Salaries And Wages 476,844 14,858 547,550 318,554 4,143
Selling And Marketing Expense 104,176 22,050 48,893 11,329 3,431
Total Expenses 1.8M 481,862 1.0M 1.0M 273,669
Total Other Finance Cost 832.00 272.00 -- 8,976 286.00
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Cash And Cash Equivalents 1.2M 679,005 965,164 705,700 63,327
Cash Cash Equivalents And Short Term Investments 1.3M 824,585 965,164 705,700 63,327
Cash Financial 1.2M 679,005 965,164 705,700 63,327
Other Short Term Investments 145,580 145,580 -- -- --
Receivables 22,228 40,284 69,502 229,604 3,215
Prepaid Assets 14,325 61,737 48,066 56,475 91,658
Current Assets 1.3M 926,606 1.1M 991,779 158,200
Gross PPE 6,138 6,138 6,138 6,138 6,138
Accumulated Depreciation -6,089 -6,078 -6,067 -6,055 -6,030
Net PPE 49.00 60.00 71.00 83.00 108.00
Goodwill And Other Intangible Assets 1.00 1.00 1.00 1.00 1.00
Other Intangible Assets 1.00 1.00 1.00 1.00 --
Investments And Advances -- -- 145,580 -- --
Total Non Current Assets 50.00 61.00 145,652 84.00 109.00
Total Assets 1.3M 926,667 1.2M 991,863 158,309
Accounts Payable -- -- -- 2.8M --
Payables -- -- -- 2.8M --
Payables And Accrued Expenses 868,486 2.7M 3.5M 2.8M 3.6M
Current Liabilities 868,486 2.7M 3.5M 2.8M 3.6M
Long Term Debt 3.4M 4.9M 4.7M 4.9M 4.8M
Long Term Debt And Capital Lease Obligation 3.4M 4.9M 4.7M 4.9M 4.8M
Total Non Current Liabilities Net Minority Interest 3.9M 5.4M 5.2M 5.4M 5.3M
Total Liabilities Net Minority Interest 4.8M 8.1M 8.7M 8.2M 8.8M
Common Stock 47.5M 45.0M 44.4M 43.9M 42.5M
Capital Stock 47.5M 45.0M 44.4M 43.9M 42.5M
Additional Paid In Capital 14.2M 13.8M 13.8M 13.2M 12.9M
Retained Earnings -67.6M -67.1M -67.0M -65.9M -64.6M
Common Stock Equity -3.5M -7.2M -7.5M -7.2M -8.7M
Stockholders Equity -3.5M -7.2M -7.5M -7.2M -8.7M
Total Equity Gross Minority Interest -3.5M -7.2M -7.5M -7.2M -8.7M
Total Capitalization -16,519 -2.3M -2.8M -2.3M -3.9M
Net Tangible Assets -3.5M -7.2M -7.5M -7.2M -8.7M
Tangible Book Value -3.5M -7.2M -7.5M -7.2M -8.7M
Working Capital 470,352 -1.8M -2.4M -1.8M -3.4M
Invested Capital -16,519 -2.3M -2.8M -2.3M -3.9M
Total Debt 3.4M 4.9M 4.7M 4.9M 4.8M
Net Debt 2.3M 4.2M 3.7M 4.2M 4.7M
Share Issued 183.7M 147.5M 145.3M 140.6M 87.1M
Ordinary Shares Number 183.7M 147.5M 145.3M 140.6M 87.1M
Machinery Furniture Equipment 6,138 6,138 6,138 -- 6,138
Non Current Deferred Liabilities 486,921 486,921 486,921 486,921 486,921
Non Current Deferred Taxes Liabilities 486,921 486,921 486,921 486,921 486,921
Other Equity Interest 2.4M 1.2M 1.4M 1.5M 521,735
Other Properties -- -- -- 6,138 --
Other Receivables -- 15,760 -- 200,000 --
Taxes Receivable 22,228 24,524 69,502 29,604 3,215
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024
Operating Cash Flow -2.9M -801,212 337,466 -1.8M -40,425
Cash Flow From Continuing Operating Activities -2.9M -801,212 337,466 -1.8M -40,425
Depreciation And Amortization 11.00 11.00 12.00 25.00 25.00
Depreciation Amortization Depletion 11.00 11.00 12.00 25.00 25.00
Stock Based Compensation 476,844 14,858 547,550 318,554 4,143
Change In Working Capital -2.0M -760,172 909,489 -984,448 112,864
Change In Receivables 18,056 29,218 160,102 -226,389 17,512
Change In Payables And Accrued Expense -2.1M -775,719 740,978 -793,242 67,846
Other Non Cash Items 192,560 172,853 164,967 162,711 157,102
Purchase Of Investment 0.00 0.00 -145,580 -- 0.00
Net Investment Purchase And Sale 0.00 0.00 -145,580 -- 0.00
Investing Cash Flow 0.00 0.00 -145,580 -- 0.00
Cash Flow From Continuing Investing Activities 0.00 0.00 -145,580 -- 0.00
Issuance Of Capital Stock 3.4M -- -- 2.5M 0.00
Net Common Stock Issuance 3.4M -- -- 2.5M 0.00
Financing Cash Flow 3.4M 515,053 67,578 2.5M 0.00
Cash Flow From Continuing Financing Activities 3.4M 515,053 67,578 2.5M 0.00
Changes In Cash 477,700 -286,159 259,464 642,373 -40,425
Beginning Cash Position 679,005 965,164 705,700 63,327 103,752
End Cash Position 1.2M 679,005 965,164 705,700 63,327
Free Cash Flow -2.9M -801,212 337,466 -1.8M -40,425
Change In Prepaid Assets 47,412 -13,671 8,409 35,183 27,506
Common Stock Issuance 3.4M -- -- 2.5M 0.00
Depreciation 11.00 11.00 12.00 25.00 25.00
Net Foreign Currency Exchange Gain Loss -- -- 0.00 0.00 --
Net Income From Continuing Operations -578,751 -228,762 -1.3M -1.3M -314,559
Proceeds From Stock Option Exercised 13,680 32,886 67,578 0.00 0.00
NEWS
Loading news...
TRENDING
Loading...